| Dr Edgar Augusto Cardona-traverzo, MD | |
|
Font Matelo Ave 355, Ryder Medical & Professional Bldg, Suite 213, Humacao, PR 00791 | |
| (787) 638-9705 | |
| (787) 656-5809 |
| Full Name | Dr Edgar Augusto Cardona-traverzo |
|---|---|
| Gender | Male |
| Speciality | Surgery |
| Location | Font Matelo Ave 355, Ryder Medical & Professional Bldg, Humacao, Puerto Rico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366440364 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 9172 (Puerto Rico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Edgar Augusto Cardona-traverzo, MD Po Box 337, Las Piedras, PR 00771-0337 Ph: (787) 638-9705 | Dr Edgar Augusto Cardona-traverzo, MD Font Matelo Ave 355, Ryder Medical & Professional Bldg, Suite 213, Humacao, PR 00791 Ph: (787) 638-9705 |
News Archive
International health advocates and drug industry representatives are lobbying U.S. lawmakers and the Bush administration for their support in the dispute over Thailand's decision to issue compulsory licenses for medications, including some antiretroviral drugs, CongressDaily reports (Vaughan, CongressDaily , 4/26).
Scientists at the Walter Reed Army Institute for Research demonstrated that biomarkers associated with traumatic brain injury were elevated among law enforcement and military personnel, particularly in active duty participants with longer duration of service.
Trius Therapeutics, Inc. today announced results from its Phase 1 clinical trial to evaluate the ability of torezolid to penetrate into the lung for potential use to treat lung infections. In this study a 200 mg dose of torezolid phosphate was administered orally once-daily for three days to healthy adult volunteers. The trial achieved its primary goal of establishing the steady-state plasma pharmacokinetics and distribution of active drug into epithelial lining fluid (ELF).
W. L. Gore & Associates (Gore) today announced that Instituto Nacional De Cardiologia in Mexico City, Mexico, is the first hospital in the country to use the GORE® HELEX Septal Occluder for the transcatheter closure of an atrial septal defect (ASD). Department Chief, Dr. Carlos Zabal and Dr. Jose Garcia Montes of the Instituto Nacional de Cardiologia, in Mexico City, achieved the milestone procedure in March, 2010.
Hospital care providers need to be more aware that cardiac arrest from a medication-induced heart rhythm problem is a rare but potentially catastrophic event in patients, according to a joint scientific statement from the American Heart Association and American College of Cardiology.
› Verified 6 days ago
Freddie Eliu Velazquez-feliciano, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: #5 Dufresne St., Humacao, PR 00792 Phone: 787-656-5252 | |
Dr. Elsa V Lopez Ramirez, MD Surgery Medicare: Medicare Enrolled Practice Location: Cl Esmeralda E-10, Humacao, PR 00791 Phone: 787-285-0760 Fax: 787-285-0760 | |
Raul L Ramos Pereira, Surgery Medicare: Not Enrolled in Medicare Practice Location: Ryder Memorial Hospital, 355 Ave Font Martelo, Humacao, PR 00792 Phone: 787-852-0768 | |
Mr. Jose Rafael Alvarez, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: B-11 Quintas De Candelero, Humacao, PR 00791 Phone: 787-852-0208 Fax: 787-852-0208 | |
Dr. Jose Antonio Gomez, Surgery Medicare: Accepting Medicare Assignments Practice Location: 9 Calle Flor Gerena N, Humacao, PR 00791 Phone: 787-850-7500 |